Mario Petrini

7PUBLICATIONS
39CO-AUTHORS
Molecular targetsMedical mycologyHaematological tumoursMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 05, 2023
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.

Emmanuel Bachy, Kerry J Savage, Huiqiang Huang

|Jun 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.

Simone Ferrero, Daniele Grimaldi, Elisa Genuardi

|Apr 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial.

Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh

|Mar 31, 2022
Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice.

Lorenzo Iovino, Kirsten Cooper, Paul deRoos

|Mar 24, 2022
Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review.

Francesco Mazziotta, Gabriele Buda, Maria Livia Del Giudice

|Feb 15, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.

Beatrice Casadei, Lisa Argnani, Alessandro Broccoli

Pageof 2

Frequent Collaborators

2 joint publications

Piero Maria Stefani

2 joint publications

Pier Luigi Zinzani

1 joint publications

Lisa Argnani

1 joint publications

Carlo Visco